checkAd

     157  0 Kommentare AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV - Seite 3

    Contacts:

    Investors:
    LHA Investor Relations
    Yvonne Briggs, 310-691-7100
    ybriggs@lhai.com 

    or

    Bruce Voss, 310-691-7100
    bvoss@lhai.com 

    Media:
    ModeX Media Relations
    media@modextx.com


    Lesen Sie auch

    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV - Seite 3 • Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal antibodies and minimal anti-drug antibodies WESTON, …